CBIZ, Inc. (CBZ)

G1 Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	109.08	41.04	120.97	105.35	70.89	78.3
Depreciation & Amortization	78.91	48.06	36.27	32.9	27.08	23.14
Loss (Gain) From Sale of Assets	-4.93	-4.93	-0.18	-0.41	-6	0.51
Stock-Based Compensation	21.06	13.84	12.29	14.69	11.41	8.87
Provision & Write-off of Bad Debts	4.41	3.79	1.55	1.17	3.05	4.41
Other Operating Activities	15.78	-1.5	11.65	14.48	11.45	-0.91
Change in Accounts Receivable	1.11	48.22	-36.09	-61.11	-17.04	6.71
Change in Accounts Payable	-15.06	-18.85	2.21	14.36	3.31	-8.8
Change in Income Taxes	15.13	-7.54	-5.92	-5.58	-4.11	-0.24
Change in Other Net Operating Assets	-101.36	1.57	10.76	10.28	31.11	34.93
Operating Cash Flow	124.13	123.69	153.51	126.13	131.15	146.85
Operating Cash Flow Growth	-16.25%	-19.42%	21.70%	-3.83%	-10.69%	49.56%
Capital Expenditures	-19.07	-12.91	-23.05	-8.64	-8.98	-11.58
Sale of Property, Plant & Equipment	7.13	7.13	3.06	3.02	-	-
Cash Acquisitions	-1,065	-1,088	-53.11	-79.14	-66.73	-71.43
Divestitures	0.29	-	-	-	9.71	0.71
Other Investing Activities	-31.66	-35.98	-6.29	-14.36	-16	35.89
Investing Cash Flow	-1,108	-1,129	-79.39	-99.12	-82.01	-46.41
Long-Term Debt Issued	-	2,488	1,224	824.9	852.1	592.35
Long-Term Debt Repaid	-	-1,379	-1,177	-714.5	-804.8	-589.85
Net Debt Issued (Repaid)	1,193	1,109	46.7	110.4	47.3	2.5
Issuance of Common Stock	-	-	8.76	10.04	7.31	6.49
Repurchase of Common Stock	-79.36	-11.51	-73.83	-129.83	-100.49	-58.54
Other Financing Activities	-99.06	-61.38	-58.75	-7.95	-23.13	-27.06
Financing Cash Flow	1,014	1,036	-77.11	-17.34	-69.01	-76.61
Net Cash Flow	30.08	30.02	-3	9.67	-19.86	23.83
Free Cash Flow	105.07	110.78	130.46	117.49	122.17	135.27
Free Cash Flow Growth	-19.13%	-15.08%	11.03%	-3.83%	-9.68%	60.44%
Free Cash Flow Margin	4.34%	6.11%	8.20%	8.32%	11.06%	14.03%
Free Cash Flow Per Share	1.76	2.10	2.58	2.24	2.27	2.44
Cash Interest Paid	25.69	25.69	19.13	7.42	3.35	4.74
Cash Income Tax Paid	37.54	37.54	39.98	27.82	17	25.94
Levered Free Cash Flow	21.28	-11.65	79.44	108.68	118.45	109.61
Unlevered Free Cash Flow	69.41	9.84	92.02	113.71	120.87	112.72
Change in Working Capital	-100.17	23.4	-29.04	-42.04	13.27	32.61

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q